MARKET

CRMD

CRMD

Cormedix
NASDAQ
7.15
-0.07
-0.90%
Opening 14:44 02/18 EST
OPEN
7.21
PREV CLOSE
7.21
HIGH
7.32
LOW
7.09
VOLUME
673.29K
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
562.95M
P/E (TTM)
3.480
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CRMD last week (0209-0213)?
Weekly Report · 2d ago
CorMedix Inc. to Present at Major Healthcare Investor Conferences
Reuters · 6d ago
Cormedix: Rezzayo and DefenCath Prophylaxis Upside Underscores Buy Rating and $13 DCF-Based Target
TipRanks · 02/11 16:45
Cormedix: Steady Near-Term Base with High-Impact Label Expansion Catalysts Justifying a Buy Rating
TipRanks · 02/11 16:15
Analyst Expectations For Cormedix's Future
Benzinga · 02/11 13:00
CorMedix Is Maintained at Buy by D. Boral Capital
Dow Jones · 02/11 12:19
CorMedix Price Target Maintained With a $14.00/Share by D. Boral Capital
Dow Jones · 02/11 12:19
Cormedix (CRMD) Receives a Buy from RBC Capital
TipRanks · 02/11 12:09
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.